A Mecklenbräuker

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia

K Malinowska-Ozdowy, Christian Frech, Andreas Schönegger et al. · Leukemia · 2015 · 126 citations · Full text

Medicine, Genetics, Oncology +17

Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia

Cornelia Vesely, Christian Frech, Cornelia Eckert et al. · Leukemia · 2016 · 53 citations · Full text

Medicine, Genetics, Oncology +17

Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia

Ulrike Kaindl, Maria Morak, C Portsmouth et al. · Leukemia · 2013 · 40 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Minimal Residual Disease–based Treatment is Adequate for Relapse-prone Childhood Acute Lymphoblastic Leukemia with an intrachromosomal amplification of chromosome 21: The experience of the ALL-BFM 2000 trial

Andishe Attarbaschi, R Panzer-Grümayer, Georg Mann et al. · Klinische Pädiatrie · 2014 · 19 citations

Medicine, Hematology, Oncology +17

Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia

Margarita Maurer‐Granofszky, Stefan Köhrer, Susanna Fischer et al. · Haematologica · 2023 · 11 citations · Full text

Medicine, Hematology, Oncology +17